As AI-powered dental software launches accelerate in 2026, Canadian dental practices face a regulatory landscape that differs significantly from the United States. Health Canada's Software as a Medical Device (SaMD) framework, combined with provincial practice-level guidelines from bodies like the Royal College of Dental Surgeons of Ontario (RCDSO), means that adopting AI tools requires more than evaluating features — it requires understanding where Canadian regulations draw different lines.
As of June 2026, the dental industry is experiencing a surge of AI product announcements. Dentsply Sirona's Smart View Detect, an FDA-cleared AI diagnostic aid for CBCT scans, launched earlier this year. Oryx Dental debuted AI-powered pediatric practice tools at the American Academy of Pediatric Dentistry conference in May. Videa introduced Ambient Intelligence, a conversational AI system designed to analyse patient-provider interactions. For Canadian dentists in Ontario and the Greater Toronto Area evaluating these tools, the critical question is not whether AI is coming to dentistry — it is already here — but how Canadian regulations apply to what you can and cannot use in your practice.
Health Canada's SaMD Framework: The Basics
Health Canada regulates AI-powered medical software under its Medical Device Regulations, classifying qualifying software as Software as a Medical Device (SaMD). According to Health Canada's regulatory framework, software that is intended to be used for a medical purpose — including diagnosis, treatment, or monitoring — without being part of a physical medical device is subject to medical device licensing requirements.
This classification matters because software that analyses radiographic images, assists in treatment planning, or provides diagnostic recommendations may fall under SaMD regulations. If it does, the software requires a Medical Device Licence (MDL) from Health Canada before it can be legally marketed or sold in Canada.
The key distinction for dental professionals: FDA clearance in the United States does not constitute Health Canada authorization. A product that has received FDA 510(k) clearance or De Novo classification must still undergo a separate regulatory review under Health Canada before it can be legally used in Canadian clinical settings. Practices that adopt U.S.-cleared-but-not-Canadian-licensed tools may be operating outside regulatory compliance.
Pro Tip: Before purchasing any AI dental software marketed as a diagnostic aid, search the Health Canada Medical Devices Active Licence Listing (MDALL) database for the product or manufacturer name. If the product does not appear, it has not received a Canadian medical device licence — proceed with caution and consult your regulatory obligations.
What Counts as SaMD in Dentistry?
Not every piece of AI-powered dental software qualifies as SaMD. Health Canada's classification depends on the software's intended purpose. Here is how different categories of dental AI tools typically fall along the regulatory spectrum:
Likely Classified as SaMD
- AI diagnostic imaging analysis: Software that analyses radiographs, CBCT scans, or intraoral images to detect pathology (caries, periapical lesions, bone loss) is performing a medical purpose and likely requires an MDL.
- AI treatment planning assistants: Software that recommends treatment protocols based on clinical data analysis may meet the threshold if it influences clinical decision-making.
- Automated cephalometric analysis: AI tools that perform cephalometric tracing and measurements for orthodontic planning typically qualify as SaMD.
Likely Not Classified as SaMD
- Practice management and scheduling AI: Software that optimizes appointment scheduling, predicts no-shows, or manages patient recall does not perform a medical function and falls outside SaMD regulation.
- Patient communication portals: AI-powered chatbots, automated appointment reminders, and patient intake systems are administrative tools, not medical devices.
- Revenue cycle and billing analytics: AI that analyses billing patterns, identifies coding errors, or predicts insurance claim outcomes serves a business function, not a clinical one.
- General documentation tools: AI transcription and note-generation tools that assist with clinical documentation — without making diagnostic recommendations — typically fall below the SaMD threshold, though practices should still evaluate privacy implications under the Personal Information Protection and Electronic Documents Act (PIPEDA).
The regulatory grey area lies with tools that describe themselves as "clinical decision support" — software that surfaces information for the clinician's review without making explicit diagnostic claims. Health Canada evaluates these on a case-by-case basis, considering how much the software influences the clinical decision and whether a healthcare professional could reasonably reach the same conclusion without the software's output.
RCDSO Practice-Level Guidelines for Ontario Dentists
Beyond Health Canada's device-level regulation, the Royal College of Dental Surgeons of Ontario (RCDSO) sets practice-level guidelines that determine how Ontario dentists may use AI tools in patient care. Several RCDSO principles apply directly to AI adoption:
- Standard of care: AI tools do not replace the dentist's clinical judgment. The RCDSO holds the dentist — not the software — responsible for diagnosis and treatment decisions. Using an AI tool that produces an incorrect recommendation does not absolve the practitioner of liability.
- Informed consent: If AI analysis contributes to a diagnosis or treatment recommendation, the patient should be informed that AI was used as part of the clinical process. Transparency about tool usage is consistent with RCDSO informed consent requirements.
- Record-keeping: Any AI-generated findings that influence clinical decisions must be documented in the patient record in a manner that meets RCDSO documentation standards. This includes preserving the AI output alongside the clinician's interpretation.
- Privacy compliance: AI tools that process patient data — whether images, health histories, or appointment records — must comply with both PIPEDA and Ontario's Personal Health Information Protection Act (PHIPA). Cloud-based AI tools that transmit patient data to servers outside Canada require particular scrutiny.
Pro Tip: Create a one-page AI tool inventory for your practice listing every AI-powered tool you use, its regulatory classification (SaMD or not), its Health Canada licence status, its data residency location, and the date of your last compliance review. Update this inventory annually. If an RCDSO peer assessment or quality assurance review asks about your technology stack, this document demonstrates due diligence.
A Practical Compliance Checklist for Canadian Practices
Before adopting any AI-powered dental tool, Ontario practices should work through the following verification steps:
- Determine the tool's regulatory classification. Is it performing a medical function (diagnosis, treatment planning) or an administrative function (scheduling, billing)? Medical function tools may require an MDL.
- Search the Health Canada MDALL database. If the tool claims to be a medical device or diagnostic aid, verify that it holds a current Medical Device Licence in Canada.
- Do not assume U.S. clearance applies in Canada. FDA clearance and Health Canada licensing are separate processes. A product marketed in the U.S. may not be legally available for clinical use in Canada.
- Review data residency and privacy compliance. Confirm where patient data is stored and processed. Ensure the vendor provides a written data processing agreement that complies with PIPEDA and PHIPA.
- Confirm RCDSO documentation compatibility. Verify that AI-generated outputs can be saved in a format that meets RCDSO record-keeping requirements.
- Assess liability implications. Understand that clinical liability remains with the practitioner. Document how AI findings are reviewed, interpreted, and either accepted or overridden in each patient case.
What Is Coming Next in Canadian Dental AI Regulation
Health Canada has been actively working on guidance for AI and machine learning-based SaMD, aligning with international efforts through the International Medical Device Regulators Forum (IMDRF). For dental practices, this means the regulatory framework is likely to become more detailed — not less — over the next two to three years. Practices that establish compliance habits now will be better positioned when more specific dental AI regulations arrive.
The Canadian Dental Association (CDA) has also signalled interest in developing profession-wide guidance for AI adoption, recognizing that dental AI tools raise unique considerations around scope of practice, delegation, and interprofessional collaboration. Ontario dentists should monitor both CDA and RCDSO communications for updated guidance as it is released.
Pro Tip: Subscribe to the RCDSO Dispatch newsletter and the CDA's Essentials publication to stay current on AI regulatory guidance as it develops. Regulatory updates in this space are moving faster than the typical annual review cycle — quarterly check-ins on guidance documents are a prudent habit for 2026 and beyond.
Frequently Asked Questions
Q: Can Ontario dentists legally use AI diagnostic tools that only have FDA clearance?
FDA clearance does not authorize a product for clinical use in Canada. If an AI diagnostic tool qualifies as Software as a Medical Device under Health Canada's Medical Device Regulations, it requires a separate Medical Device Licence from Health Canada. Using an unlicensed medical device in clinical practice may create regulatory and liability exposure. Verify Canadian licensing status through the MDALL database before clinical adoption.
Q: Does using AI in my dental practice change my liability as a dentist in Ontario?
The RCDSO holds the dentist responsible for all clinical decisions, regardless of whether AI tools contributed to the diagnosis or treatment plan. AI output is an input to your clinical judgment — not a substitute for it. Document how AI findings were reviewed and interpreted in the patient record, and ensure informed consent reflects the use of AI in the clinical process.
Q: Are AI-powered practice management tools like scheduling optimizers regulated by Health Canada?
Practice management tools that perform administrative functions — scheduling, patient communication, billing analytics, recall management — do not perform a medical function and are generally not classified as SaMD. However, these tools must still comply with PIPEDA and PHIPA if they process patient health information. Data privacy requirements apply to all software that handles patient data, not just medical devices.
EBIKO Dental will continue covering regulatory developments affecting Canadian dental practices. For dental supplies and practice essentials, visit ebiko.ca.